$ACT Company News Actavis continues hot streak with

New Post Public Reply Private Reply Replies (0) Message Board

Feb 21, 2014 at 10:44 AM

$ACT Company News

Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Investors drive up price of Actavis-Forest deal 11:14 a.m. Feb. 18, 2014 - blogs.marketwatch.com
Actavis shares jump 7.8% on Forest Lab deal 9:35 a.m. Feb. 18, 2014 - Sue Chang
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis-Forest Labs is play on changes in health care 9:06 a.m. Feb. 18, 2014 - Dana Mattioli
Actavis confirms $25 bln Forest Labs acquistion 7:15 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis shares climb 10% on deal for Forest Labs 7:12 a.m. Feb. 18, 2014 - Silvia Ascarelli
Forest Lab surges 27% premarket on Actavis deal 7:09 a.m. Feb. 18, 2014 - Silvia Ascarelli
Actavis confirms $25 bln Forest Labs acquistion 7:02 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis in talks to buy Forest Labs for up to $25 bln 1:06 a.m. Feb. 18, 2014 - Dana Mattioli, Jonathan D. Rockoff and Dana Cimilluca
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Bears chip away at the S&P 1,775 support 11:00 a.m. Feb. 3, 2014 - Michael Ashbaugh

Actavis Up on Strong 4Q Earnings Beat - Analyst Blog 57 min ago - Zacks.com
This Biotech Bubble Is Bound to Burst 3:28 a.m. Today - InvestorPlace.com
Actavis PLC (ACT): Today's Featured Health Care Winner 5:00 p.m. Feb. 20, 2014 - TheStreet.com
Shares of M&A Bidders Enjoy Rare Burst of Buying 12:00 p.m. Feb. 20, 2014 - FOXBusiness
Actavis Q4 Beats Street; Guidance Affirmed For Now 10:21 a.m. Feb. 20, 2014 - Investors Business Daily
More on Actavis Q4: Warner Chilcott boosts revenue 8:44 a.m. Feb. 20, 2014 - Seeking Alpha
UPDATE: Actavis Posts Upbeat Q4 Earnings 7:48 a.m. Feb. 20, 2014 - benzinga.com
Actavis Swings to Loss on Restructuring, Write-Downs 7:33 a.m. Feb. 20, 2014 - WSJ.com
Notable earnings before Thursday’s open 12:05 a.m. Feb. 20, 2014 - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Feb. 19, 2014 - Seeking Alpha
Is It Too Soon To Call 2014 A Year Of Mergers And Acquisitions? 5:18 p.m. Feb. 19, 2014 - TheStreet.com
Medicals Among Top 20 Groups, Retailers Near Bottom 5:07 p.m. Feb. 19, 2014 - Investors Business Daily
Top-Ranked Forest Labs Soars on Buyout News - Analyst Blog 3:45 p.m. Feb. 19, 2014 - Zacks.com
After Forest Deal, Actavis Could Climb 50% 10:53 a.m. Feb. 19, 2014 - Barrons.com
Today's Unusual Social Activity Stock: Actavis (ACT) 10:15 a.m. Feb. 19, 2014 - TheStreet.com
Stock Market News for February 19, 2014 - Market News 10:06 a.m. Feb. 19, 2014 - Zacks.com
Is Weather the Only Explation? - Ahead of Wall Street 9:46 a.m. Feb. 19, 2014 - Zacks.com
Is Weather the Only Explanation? - Ahead of Wall Street 9:46 a.m. Feb. 19, 2014 - Zacks.com
UPDATE: Bank of America Reiterates on Actavis on Possible Forest Acquisition 8:48 a.m. Feb. 19, 2014 - benzinga.com
The Market Rally Resembles a Dog On a Bone 5:59 a.m. Feb. 19, 2014 - InvestorPlace.com

Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17 7:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Actavis to Present at Citi's 2014 Global Healthcare Conference 4:25 p.m. Feb. 19, 2014 - PR Newswire - PRF
Critical Alerts For Actavis, athenahealth, Seattle Genetics, JP Morgan Chase, and SodaStream Released By InvestorsObserver 9:31 a.m. Feb. 19, 2014 - PR Newswire - PRF
Actavis to buy Forest Labs for $25B and GT Advanced Tech acquires exclusive rights from Kyma Tech 12:31 a.m. Feb. 19, 2014 - ACCESSWIRE
Acquisition of Forest Laboratories, Inc. by Actavis plc May Not Be in Shareholders' Best Interests 9:02 p.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Scheduled for Thursday, February 20, 2014 5:13 p.m. Feb. 18, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders 5:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Forest Labs Acquisition; Outlook Stable 2:52 p.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST SHAREHOLDERS NOTICE:Johnson & Weaver, LLP Announces Investigation of the Forest Laboratories, Inc. Proposed Acquisition by Actavis plc 9:43 a.m. Feb. 18, 2014 - BusinessWire - BZX
INVESTOR BUYOUT ALERT - Offer to Acquire Forest Laboratories - Shareholder Rights Law Firm Tripp Levy PLLC Seeks Higher Price And More Information For Shareholders 8:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Host Fourth Quarter 2013 Earnings Conference Call and Webcast 8:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Treanda® Patent Challenge 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
Actavis Presents Outlook for Continued Long-Term Growth 7:15 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Refocused Global Business Structure to Maximize Evolution into Global Specialty Pharmaceuticals Leadership 7:00 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to Divest Actavis Foshan, China 4:05 p.m. Jan. 24, 2014 - PR Newswire - PRF
Actavis Comments on Notification to Allergan, Inc. of Submission of Application for Restasis® 12:41 p.m. Jan. 22, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries 9:45 p.m. Jan. 17, 2014 - PR Newswire - PRF
Actavis Confirms Court Upholds Lo Loestrin® Fe Patent 5:42 p.m. Jan. 17, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ON1 Photo RAW 2027: New AI Tools, Better Processing

Aiming for the Photography Crown ON1 isn't just tinkering on the fringes with their new Photo RAW 2027 release—they're diving headfirst into the deep end, aiming to outdo giants in the RAW processing world. I've seen my share of software updates that don't move the needle, but this one's packed to the gills with updates that photographers have been clamoring for. What's...

Clarivate Integrates Trademark Data with Microsoft AI

You know, the market's all abuzz with AI this, AI that. But today, we're getting a glimpse at something that isn't just hyped-up vaporware; it's actually useful. Clarivate Plc (NYSE:CLVT), which has carved a niche in transformative intelligence, is teaming up with Microsoft to slide their CompuMark trademark data into Microsoft Copilot via something they call IPOne. It's...

New Leadership Fuels Expansion of Black Optix Tint

Shifting Gears with New Leadership Black Optix Tint isn't just revamping its car-styling game; it's refueling the entire brand with the appointment of Jeff Stark as its new brand president. This guy's entry into the picture is like putting nitro in the tank of a franchise that's already got some serious road miles behind it. With over 15 years under his belt in the...

Cleafy's Cyber-Fraud Edge in SPARK Matrix™ 2026

What's Cookin'? Cleafy Leads in Fraud Management Lineup Eying the world through a prism of calculated risk and opportunity, Cleafy has emerged a big dog in the latest QKS Group SPARK Matrix™ for Enterprise Fraud Management, 2026. The spotlight's on their cutting-edge knack for dodging cyber fraud's punches, a distinction that hints at a deeper market shift for those who...

3W Auto-life Unveils New Products at SEMA Show 2026

Revving Up Interest at SEMA with 3W Auto-life If there's ever a mecca for car accessories in the automotive world, the SEMA Show in Las Vegas is it. Right there in the West Hall, Booth #54169, 3W Auto-life is flaunting their 2026 lineup, marking a decade of transformation in vehicle interior protection. From upgraded floor mats for the Tesla Model Y Juniper and the Toyota...

AAR's Big Bet on Notes Amid MRO Holdings Acquisition

AAR's $1.9 Billion Move in the Aviation Arena The aviation aftermarket giant AAR isn't just dipping its toes into the bond market—it's diving in headfirst with a hefty $1.9 billion in senior notes. These notes, spread across two separate issues due in 2031 and 2034, are part of a broader strategy to finance the takeover of MRO Holdings. It's a bold move, but in the...

Ceva and Mobilint's New REGULUS: A Game Changer?

A Big Leap for Physical AI Can't pretend I saw this coming—Ceva's making waves with Mobilint's new REGULUS edge AI SoC, aiming to flip the script on how we think about physical AI devices. This combo of Ceva's NeuPro NPU and SensPro AI DSP is more than just tech talk; it's a gutsy move that shows us edge devices might be the hunting ground for AI innovation. Sensors and...

ENGWE Unleashes Massive Black Friday E-Bike Discounts

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Curaleaf Takes Stake in NJ's Boone Town Dispensary

Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...

November Oil Outlook: OPEC+ Steady, Key Earnings Ahead

Oil's November Gambit: OPEC+ and U.S. Dynamics November's here, and boy, it's shaping up to be a wild one for the oil market. OPEC+ decided to stick with their oil production targets for December, leaving the supply faucets unchanged. This group, including big players like Saudi Arabia and Russia, met virtually and chose to hit the brakes on any changes just yet. With the...